Jupiter Wellness (JUPW)

Sorry, no known transcripts

Recent filings

Notice of Effectiveness - June 22, 2022

Jupiter Wellness Announces The Retirement Of Approximately 10% Of Its Outstanding Shares JUPITER, FL – - June 17, 2022

Registration statement under Securities Act of 1933 - June 13, 2022

Jupiter Wellness Just Filed Its Quarterly Report: Net Loss per Common ... - May 16, 2022

Greentree Financial Group, Inc. just provided an update on share ownership of Jupiter Wellness - May 13, 2022

Jupiter Wellness’ To Present Jw-300 Topical Burn Treatment At Scale 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference - May 4, 2022

$3 Million Annual Revenue & Ebitda Contribution To Jupiter IN A BID TO EXPEND JUPTER WELLNESS’S RESEARCH CAPABILITIES AND ENTER THE LUCRATIVE CRO BUSINESS, JUPITER WELLNESS ACQUIRED THE ASSETS OF ASCE - April 27, 2022

On April - April 22, 2022

Jupiter Wellness Appoints E-Commerce & Marketing Team To Drive Sales Of Its Growing Portfolio Of Proprietary Health And Wellness Brands - April 18, 2022

Jupiter Wellness To Launch Canisun For Shark Defense™ Sunscreen With Patented Shark Repellents - April 7, 2022

Jupiter: Journal Of Cosmetic Dermatology - April 6, 2022

Jupiter Wellness Launches Nostingz Jellyfish Protective Sunscreen Backed By Patent-Pending Formula In $13 B Sunscreen Market - April 5, 2022

Departure of Directors or Certain - March 7, 2022

Jupiter Wellness Board Of Directors, - March 1, 2022

Termination of a Material Definitive - Feb. 18, 2022

Jupiter Wellness Completes Enrollment In Double-Blind Placebo-Controlled Clinical Trial Of Jw-200 For The Treatment Of Actinic Keratosis - Feb. 18, 2022

Jupiter Wellness Merger Partner Next Frontier’S Executive Chairman Shannon Soqui Interview With Benzinga - Feb. 15, 2022

Current report, items 7.01 and 9.01 - Feb. 2, 2022

Jupiter Wellness’ Merger Partner Next Frontier Pharmaceuticals, Inc - Feb. 1, 2022

Jupiter Wellness director was just granted 25,000 options - Jan. 28, 2022

Jupiter Wellness director was just granted 25,000 options - Jan. 28, 2022

Jupiter Wellness director was just granted 25,000 options - Jan. 28, 2022

CSO of Jupiter Wellness was just granted 450,000 options - Jan. 27, 2022

Jupiter Wellness's CCO was just granted 425,000 options - Jan. 27, 2022

Jupiter Wellness's Chief Financial Officer was just granted 475,000 options - Jan. 27, 2022

Jupiter Wellness's CEO was just granted 25,000 options - Jan. 27, 2022

CSO of Jupiter Wellness was just granted 25,000 options - Jan. 27, 2022

CSO of Jupiter Wellness was just granted 25,000 options - Jan. 27, 2022

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - Jan. 26, 2022

Jupiter Wellness Announces Board Approval Of $5.0 Million Share Buyback Program - Jan. 25, 2022

Jupiter Wellness To Dividend Srm Entertainment Subsidiary - Jan. 24, 2022

Jupiter Wellness’ Merger Partner Next Frontier Pharmaceuticals, Inc. Enters Psychedelic Drug Development And Api Market - Jan. 20, 2022

Entry into a Material Definitive - Jan. 13, 2022

Jupiter Wellness Issues Letter To Stockholders Dear Fellow Stockholders, - Jan. 10, 2022

Jupiter Wellness Issues Letter To Stockholders Dear Fellow Stockholders, - Dec. 29, 2021

Jupiter Wellness Signs Definitive Agreement To Merge With Next Frontier Pharmaceuticals, A Leading Drug Developer And Manufacturer Of Synthetic Cannabinoid Pharmaceuticals - Dec. 14, 2021

Jupiter Wellness Signs Definitive Agreement To Merge With Next Frontier Pharmaceuticals, A Leading - Dec. 9, 2021

CCO of Jupiter Wellness was just granted 875,000 options - Nov. 29, 2021

CEO of Jupiter Wellness was just granted 875,000 options - Nov. 29, 2021

Jupiter Wellness's Chief Financial Officer was just granted 875,000 options - Nov. 29, 2021

CSO of Jupiter Wellness was just granted 875,000 options - Nov. 29, 2021

Jupiter Wellness Announces Jw-300 Clinical Trial Results - Nov. 16, 2021

CSO of Jupiter Wellness just picked up 200,000 shares - Nov. 15, 2021

Jupiter Wellness's Chief Financial Officer just picked up 100,000 shares - Nov. 15, 2021

Jupiter Wellness Completes Pre-Ind Meeting With The U.S. Food & - Nov. 12, 2021

Jupiter Wellness Just Filed Its Quarterly Report: Net Loss per Common ... - Nov. 12, 2021

Jupiter Wellness Sponsors Jupiter Wellness Acquisition Corp Spac Targeting Ai Medical Therapeutics And Diagnostics - Nov. 3, 2021

Jupiter Wellness releases salary data. CEO sees compensation rise 4371% - Nov. 3, 2021

Other preliminary proxy statements - Oct. 20, 2021

Jupiter Wellness Announces First Patient Dosing For Double-Blinded Placebo Controlled Trial Of Jw-300 For The Treatment Of First Degree Burns - Oct. 19, 2021

Jupiter Wellness Provides Shareholder Update On Multiple Clinical & Commercial Milestones - Oct. 8, 2021

CEO of Jupiter Wellness just picked up 51,556 shares - Oct. 7, 2021

As previously announced on April - Oct. 1, 2021

Jupiter Wellness Announces Multi-Year Extension Of - Sept. 8, 2021

Jupiter Wellness Submitted A Pre-Ind Meeting Request With - Aug. 23, 2021

Amendments to Articles of Incorporation or - Aug. 23, 2021

CCO of Jupiter Wellness just picked up 9,416 shares - Aug. 18, 2021

Jupiter Wellness's Chief Operating Officer was just granted 155,444 options - Aug. 18, 2021

CSO of Jupiter Wellness just picked up 14,124 shares - Aug. 18, 2021

Jupiter Wellness's Chief Financial Officer just picked up 14,124 shares - Aug. 18, 2021

CEO of Jupiter Wellness just picked up 18,832 shares - Aug. 18, 2021

Jupiter Wellness Just Filed Its Quarterly Report: Net Loss per Common ... - Aug. 16, 2021

Jupiter Wellness Applies For Ind Number From The Us Food - Aug. 16, 2021

Aegis Capital Corp. Acted As Sole Bookrunner On A $32.5 Million Follow-On Offering Of Common Stock And Warrants For Jupiter Wellness, Inc. (Nasdaq:Jupw) - July 30, 2021

Jupiter Wellness's Chief Financial Officer just disposed of 75,000 shares - July 27, 2021

Jupiter Wellness's Chief Compliance Officer just disposed of 150,000 shares - July 27, 2021

Jupiter Wellness's Chief Executive Officer just disposed of 250,000 shares - July 27, 2021

Jupiter Wellness's Chief Operating Officer just disposed of 15,884 shares - July 27, 2021

Jupiter Wellness's Chief Science Officer just disposed of 50,000 shares - July 27, 2021

Jupiter Wellness just filed a prospectus, suggesting it plans to soon issue some securities - July 26, 2021

CBD Life Sciences Inc. just filed a prospectus, suggesting it plans to soon issue some securities - July 23, 2021

Notice of Effectiveness - July 21, 2021

General form for registration of securities under the Securities Act of 1933 - July 20, 2021

CBD Life Sciences: Jupiter Wellness Announces Multi-Year Distribution Agreement With Rigour International For Expansion In Asia - July 19, 2021

General form for registration of securities under the Securities Act of 1933 - July 19, 2021

CBD Life Sciences: Press Release, Dated July 13, 2021 - July 13, 2021

CBD Life Sciences: Press Release, Dated July 9, 2021 - July 9, 2021

Major owner of CBD Life Sciences Inc. was just granted 35,600 options - July 2, 2021

CBD Life Sciences Inc.'s Chief Financial Officer was just granted 33,500 options - July 2, 2021

Major owner of CBD Life Sciences Inc. was just granted 50,800 options - July 2, 2021

CBD Life Sciences Inc. director was just granted 33,500 options - July 2, 2021

Current report, items 1.04, 7.01, and 9.01 - June 22, 2021

Current report, items 1.01, 3.02, 7.01, and 9.01 - June 17, 2021

Notice of Effectiveness - June 15, 2021

CBD Life Sciences, Inc. (CBDL) Launches 2nd Retail Location - June 15, 2021

General form for registration of securities under the Securities Act of 1933 - June 11, 2021

On May - May 28, 2021

CBD Life Sciences, Inc. (CBDL) Announces Retail Store Updates - May 19, 2021

CBD Life Sciences Inc. Just Filed Its Quarterly Report: Net Loss per Common ... - May 17, 2021

CBD Life Sciences, Inc. (CBDL) Launches Top Selling Pain Cream & Gummies on its Amazon Store - May 17, 2021

On May - May 13, 2021

Quarterly Report - May 7, 2021

CBD Life Sciences, Inc. (CBDL) Announces the Official Grand Opening of its Amazon Store - May 6, 2021

CBD Life Sciences: Press Release Dated April 29, 2021 Exhibit 99.1 - April 29, 2021

Current report, items 7.01 and 9.01 - April 20, 2021

CBD Life Sciences: Press Release Dated April 16, 2021 Exhibit 99.1 - April 16, 2021

CBD Life Sciences, Inc. (CBDL) Issues Strategic Corporate Overview. - April 14, 2021

Annual report [Section 13 and 15(d), not S-K Item 405] - April 12, 2021

Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 - March 31, 2021

Attorney Letter with Respect to Current Information - March 30, 2021

Sorry, no schedule available for this company

Jupiter Wellness Completes Enrollment in Double-Blind Placebo-Controlled Clinical Trial of JW-200 for the Treatment of Actinic Keratosis - Feb. 18, 2022

Nomination Committee for Biovica for the 2022 Annual General Meeting - Feb. 18, 2022

Gambier Gold Corp. (TSX-V: GGAU) Corporate Update - Feb. 18, 2022

Jupiter Wellness Merger Partner Next Frontier's Executive Chairman Shannon Soqui Interview with Benzinga - Feb. 15, 2022

Jupiter Wellness’ CEO Brian John & Next Frontier’s Executive Chairman Shannon Soqui Interviewed on SNN Network - Feb. 2, 2022

Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Announces Plans for Oral Dronabinol Solution for the Treatment of Alzheimer's Disease Agitation - Feb. 1, 2022

Jupiter Wellness Announces Board Approval of $5.0 Million Share Buyback Program - Jan. 25, 2022

Jupiter Wellness to Dividend SRM Entertainment Subsidiary to its Stockholders - Jan. 24, 2022

Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Enters Psychedelic Drug Development and API Market - Jan. 20, 2022

Jupiter Wellness Issues Letter to Stockholders - Jan. 10, 2022

JUPITER WELLNESS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Jupiter Wellness, Inc. - JUPW - Jan. 4, 2022

JUPITER WELLNESS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Jupiter Wellness, Inc. - JUPW - Dec. 14, 2021

Jupiter (JUPW) Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Jupiter Wellness, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – JUPW - Dec. 11, 2021

Jupiter Wellness Signs Definitive Agreement to Merge with Next Frontier Pharmaceuticals, a Leading Drug Developer and Manufacturer of Synthetic Cannabinoid Pharmaceuticals - Dec. 9, 2021

Jupiter Wellness Announces JW-300 Clinical Trial Results - Nov. 16, 2021

TG Venture Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing on November 22, 2021 - Nov. 16, 2021

Jupiter Wellness Completes Pre-IND meeting with the U.S. Food & Drug Administration for JW-100 in the Treatment of Eczema - Nov. 11, 2021

Jupiter Wellness Sponsors Jupiter Wellness Acquisition Corp SPAC Targeting AI Medical Therapeutics and Diagnostics - Nov. 3, 2021

Jupiter Wellness Announces First Patient Dosing for Double-Blinded Placebo Controlled Trial of JW-300 for the Treatment of First Degree Burns - Oct. 19, 2021

BK Technologies Appoints Sean Conroy as Director of Supply Chain - Oct. 19, 2021

 


Feedback